BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22984080)

  • 1. Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells.
    Lee SR; Rutan JA; Monteith AJ; Jones SZ; Kang SA; Krum KN; Kilmon MA; Roques JR; Wagner NJ; Clarke SH; Vilen BJ
    J Immunol; 2012 Oct; 189(8):3859-68. PubMed ID: 22984080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages.
    Gilbert MR; Wagner NJ; Jones SZ; Wisz AB; Roques JR; Krum KN; Lee SR; Nickeleit V; Hulbert C; Thomas JW; Gauld SB; Vilen BJ
    J Immunol; 2012 Jul; 189(2):711-20. PubMed ID: 22675201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.
    Gilbert MR; Carnathan DG; Cogswell PC; Lin L; Baldwin AS; Vilen BJ
    J Immunol; 2007 Apr; 178(8):4803-10. PubMed ID: 17404261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation.
    Dye JR; Palvanov A; Guo B; Rothstein TL
    J Immunol; 2007 Jul; 179(1):229-35. PubMed ID: 17579042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation.
    Mizuno T; Rothstein TL
    J Immunol; 2005 Mar; 174(6):3369-76. PubMed ID: 15749869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.
    Jiang C; Foley J; Clayton N; Kissling G; Jokinen M; Herbert R; Diaz M
    J Immunol; 2007 Jun; 178(11):7422-31. PubMed ID: 17513793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neuraminidase in TLR4-MAPK signalling and the release of cytokines by lupus serum-stimulated mesangial cells.
    Sundararaj K; Rodgers J; Angel P; Wolf B; Nowling TK
    Immunology; 2021 Apr; 162(4):418-433. PubMed ID: 33314123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
    Mizuno T; Rothstein TL
    J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.
    Qian Y; Santiago C; Borrero M; Tedder TF; Clarke SH
    J Immunol; 2001 Feb; 166(4):2412-9. PubMed ID: 11160300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cytokine expression by an autoreactive B cell clone derived from MRL/MP-lpr/lpr mice.
    Iwasaki T; Hamano T; Fujimoto J; Ogata A; Kakishita E
    Clin Exp Immunol; 1998 Oct; 114(1):1-8. PubMed ID: 9764595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
    Okada Y; Ochi H; Fujii C; Hashi Y; Hamatani M; Ashida S; Kawamura K; Kusaka H; Matsumoto S; Nakagawa M; Mizuno T; Takahashi R; Kondo T
    J Autoimmun; 2018 Mar; 88():103-113. PubMed ID: 29146546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
    Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
    J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.
    Kilmon MA; Wagner NJ; Garland AL; Lin L; Aviszus K; Wysocki LJ; Vilen BJ
    Blood; 2007 Sep; 110(5):1595-602. PubMed ID: 17712049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies.
    Teodorovic LS; Babolin C; Rowland SL; Greaves SA; Baldwin DP; Torres RM; Pelanda R
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):E2797-806. PubMed ID: 24958853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of autoreactive B cells during innate immune responses.
    Vilen BJ; Rutan JA
    Immunol Res; 2008; 41(3):295-309. PubMed ID: 18704765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent.
    Guo B; Rothstein TL
    J Immunol; 2005 May; 174(9):5375-81. PubMed ID: 15843535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.